NFE2L2 and lymphoma: Rescue experiments using MEK1/2-specific inhibitor SL327 and Nrf-2-specific activator cheirolin in KHYG-1 and SNK-6 cells successfully reversed the stimulating or repressing effects of LMP1 upregulation or downregulation on lymphoma cell autophagy and DDP resistance, respectively.